Targeted oesophageal administration of Zn-alpha-glycoproteins (ZAG), methods and formulations thereof

摘要

The invention provides formulations and methods for ameliorating symptoms associated with metabolic disorders, such as hypoglycemia, obesity, diabetes, and the like by targeted administration to the oesphagus of a subject of Zn-α